GlobeNewswire by notified

Industry-leaders join BIOPAC for T4 Human Physiology Conference Set for August 12-14, 2019

Share

Training and Best Practices for Measuring Physiology

GOLETA, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) -- BIOPAC Systems, Inc., announced the second biennial T4 Human Physiology Conference to be held August 12-14, 2019 at the University of California Santa Barbara (UCSB). Life science researchers, educators, and students are invited to learn the latest Tools, Trends, Techniques, and Technology used in physiological measurement and interpretation. T4 sessions offer hands-on, practical tips and tricks, giving participants the latest tools and insights to pursue scientific discovery with significant amounts of data from multiple participants and devices, in or out of the lab.

BIOPAC hosts the T4 Physiology Conference to increase understanding of physiological measurements. Frazer Findlay, BIOPAC CEO, says, “BIOPAC has always placed a strong emphasis on working with partners that understand the industry and the needs of our customers. I am delighted that we’ll have partners joining us at T4 to share innovations and ideas on stimulus presentation, virtual and augmented reality, blood pressure monitoring, brain imaging, behavioral observation, and more.”

Presenters include esteemed academic speakers who are experts in their fields of research along with leading technology companies such as CNSystems (for noninvasive blood pressure) and Psychology Software Tools (for visual presentation and event marking).

Researchers and educators in physiology, psychology, neuroscience, exercise physiology, and imaging will improve their skills by understanding how technology can be optimized to yield better, more efficient research. Academic scientists, researchers, research assistants, PIs and assistant PIs, investigators, industry applied researchers, and educators will benefit from attending T4 sessions and networking with peers from around the world—26 countries were represented at the inaugural T4.

The three-day T4 conference will focus on recording and analyzing data using current technology tools and best practices. Experts in major research areas will lead targeted sessions on how to set up a lab or classroom to optimize data, prepare a subject, synchronize data, and standardize interpretation with automated scoring routines.

https://www.biopac.com/biopac-t4-human-physiology-conference/ 

About BIOPAC Systems

BIOPAC was founded in 1985 and is recognized around the world as a premier choice for life science hardware and software. Worldwide, over 99% of the top 100 universities and Global Fortune 500 companies rely on BIOPAC systems for their life science research and teaching system needs. BIOPAC makes high-quality scientific tools for physiology measurement and interpretation. BIOPAC solutions range from educational solutions to cutting edge devices for use in lab, real world, and virtual reality research environments. For more information on BIOPAC products, visit www.biopac.com.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Nokia Corporation: Repurchase of own shares on 19.04.202419.4.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 19 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 19.04.2024 Espoo, Finland – On 19 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL430,8933.30CEUX--BATE--AQEU--TQEX--Total430,8933.30 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of

Landsbankinn hf.: Results of the 2024 AGM of Landsbankinn19.4.2024 20:48:08 CEST | Press release

The annual general meeting (AGM) of Landsbankinn, held on 19 April 2024, agreed to pay a dividend amounting to ISK 16,535 million to shareholders. The dividend is equivalent to 50% of 2023 profits. The dividend will be paid in two instalments, firstly on 24 April 2024 and secondly on 16 October 2024. As a result, total dividend paid by the Bank in 2013-2024 amounts to ISK 191.7 billion. At the AGM, held in Reykjastræti 6, Helga Björk Eiríksdóttir, Chairman of the Board of Directors, delivered the report from the Board for 2023. Lilja Björk Einarsdóttir, CEO, spoke of the Bank’s operation, strategy and activities in the past operating year. The annual financial statement for the past operating year was approved, as was the proposed Remuneration Policy and remuneration to Directors of the Board. The AGM elected the Auditor General (Ríkisendurskoðun) as auditor of Landsbankinn hf. for the 2024 operating year. The Auditor General, in accordance with an authorisation to outsource tasks, and

SKEL fjárfestingafélag hf.: Styrkás finalizes the purchase of Stólpi Gámar ehf. and affiliated companies.19.4.2024 19:20:57 CEST | Press release

Reference is made to the announcement dated 31 January 2024, regarding Styrkás hf., a company 69.64% owned by SKEL fjárfestingafélag hf., signing a purchase agreement to acquire 100% of the shares in six subsidiaries of Máttarstólpi ehf. The purchase agreement was subject to the approval of the Competition Authority. The transaction was finalized today with payment of purchase price and delivering of shares in the following companies: - Stólpi Gámar ehf., id. 460121-1590, Klettagörðum 5, 104 Reykjavík: - Stólpi Smiðja ehf., id. 460121-1750, Klettagörðum 5, 104 Reykjavík; - Klettskjól ehf., id. 460121-0510, Klettagörðum 5, 104 Reykjavík; - Stólpi ehf., 460121-0430, Klettagörðum 5, 104 Reykjavík; - Tjónaþjónustan ehf., id. 460121-1670, Klettagörðum 5, 104 Reykjavík; - Alkul ehf., id. 491020-0830, Haukdælabraut 48, 113 Reykjavík. collectively referred to as "the sold companies". These companies will continue to be operated on a consolidated basis. The Enterprise value of the sold companie

Subsea 7 S.A. notification of major holding19.4.2024 19:12:34 CEST | Press release

Luxembourg –19 April 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced that, on 19 April 2024, Barclays Capital Securities Limited1 informed the Company that it had breached thresholds provided for by Luxembourg’s Transparency Law of 11 January 2008 on transparency requirements for issuers of securities as amended (the “Transparency Law”) as follows: 15 April 2024 On 15 April 2024 the total number of voting rights in the Company according to Article 8 and 9 of the Transparency Law attached to shares held by Barclays was 22,559 representing less than 0.01% of the voting rights in the CompanyOn 15 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (a) of the Transparency Law (right to recall) were 14,625,242 representing 4.80% of the voting rights in the CompanyOn 15 April 2024 the total number of voting rights in the Company attached to financial instruments with similar

HiddenA line styled icon from Orion Icon Library.Eye